136 related articles for article (PubMed ID: 33482272)
1. Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo.
Andrade F; Rafael D; Vilar-Hernández M; Montero S; Martínez-Trucharte F; Seras-Franzoso J; Díaz-Riascos ZV; Boullosa A; García-Aranda N; Cámara-Sánchez P; Arango D; Nestor M; Abasolo I; Sarmento B; Schwartz S
J Control Release; 2021 Mar; 331():198-212. PubMed ID: 33482272
[TBL] [Abstract][Full Text] [Related]
2. Effects of salinomycin and niclosamide on small cell lung cancer and small cell lung cancer circulating tumor cell lines.
Hochmair M; Rath B; Klameth L; Ulsperger E; Weinlinger C; Fazekas A; Plangger A; Zeillinger R; Hamilton G
Invest New Drugs; 2020 Aug; 38(4):946-955. PubMed ID: 31446534
[TBL] [Abstract][Full Text] [Related]
3. Selectively Targeting Breast Cancer Stem Cells by 8-Quinolinol and Niclosamide.
Cámara-Sánchez P; Díaz-Riascos ZV; García-Aranda N; Gener P; Seras-Franzoso J; Giani-Alonso M; Royo M; Vázquez E; Schwartz S; Abasolo I
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233074
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of LEF1-Mediated DCLK1 by Niclosamide Attenuates Colorectal Cancer Stemness.
Park SY; Kim JY; Choi JH; Kim JH; Lee CJ; Singh P; Sarkar S; Baek JH; Nam JS
Clin Cancer Res; 2019 Feb; 25(4):1415-1429. PubMed ID: 30446587
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor stem like cells in oral squamous cell carcinoma: An unresolved paradox.
Patel S; Shah K; Mirza S; Shah K; Rawal R
Oral Oncol; 2016 Nov; 62():139-146. PubMed ID: 27865367
[TBL] [Abstract][Full Text] [Related]
6. AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells.
Rafael D; Gener P; Andrade F; Seras-Franzoso J; Montero S; Fernández Y; Hidalgo M; Arango D; Sayós J; Florindo HF; Abasolo I; Schwartz S; Videira M
Drug Deliv; 2018 Nov; 25(1):961-972. PubMed ID: 29667444
[TBL] [Abstract][Full Text] [Related]
7. Zileuton™ loaded in polymer micelles effectively reduce breast cancer circulating tumor cells and intratumoral cancer stem cells.
Gener P; Montero S; Xandri-Monje H; Díaz-Riascos ZV; Rafael D; Andrade F; Martínez-Trucharte F; González P; Seras-Franzoso J; Manzano A; Arango D; Sayós J; Abasolo I; Schwartz S
Nanomedicine; 2020 Feb; 24():102106. PubMed ID: 31666201
[TBL] [Abstract][Full Text] [Related]
8. Effective intracellular delivery of bevacizumab via PEGylated polymeric nanoparticles targeting the CD44v6 receptor in colon cancer cells.
Baião A; Sousa F; Oliveira AV; Oliveira C; Sarmento B
Biomater Sci; 2020 Jul; 8(13):3720-3729. PubMed ID: 32500879
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cell-associated miRNAs serve as prognostic biomarkers in colorectal cancer.
Toden S; Kunitoshi S; Cardenas J; Gu J; Hutchins E; Van Keuren-Jensen K; Uetake H; Toiyama Y; Goel A
JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30895943
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in
Grillet F; Bayet E; Villeronce O; Zappia L; Lagerqvist EL; Lunke S; Charafe-Jauffret E; Pham K; Molck C; Rolland N; Bourgaux JF; Prudhomme M; Philippe C; Bravo S; Boyer JC; Canterel-Thouennon L; Taylor GR; Hsu A; Pascussi JM; Hollande F; Pannequin J
Gut; 2017 Oct; 66(10):1802-1810. PubMed ID: 27456153
[TBL] [Abstract][Full Text] [Related]
11. FOLFOX Therapy Induces Feedback Upregulation of CD44v6 through YB-1 to Maintain Stemness in Colon Initiating Cells.
Ghatak S; Hascall VC; Markwald RR; Misra S
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33451103
[TBL] [Abstract][Full Text] [Related]
12. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma.
Padthaisong S; Thanee M; Namwat N; Phetcharaburanin J; Klanrit P; Khuntikeo N; Titapun A; Sungkhamanon S; Saya H; Loilome W
J Transl Med; 2020 Feb; 18(1):64. PubMed ID: 32039729
[TBL] [Abstract][Full Text] [Related]
14. Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells.
Barkeer S; Chugh S; Karmakar S; Kaushik G; Rauth S; Rachagani S; Batra SK; Ponnusamy MP
BMC Cancer; 2018 Nov; 18(1):1157. PubMed ID: 30466404
[TBL] [Abstract][Full Text] [Related]
15. Role of miRNA dynamics and cytokine profile in governing CD44v6/Nanog/PTEN axis in oral cancer: modulating the master regulators.
Patel S; Rawal R
Tumour Biol; 2016 Nov; 37(11):14565-14575. PubMed ID: 27612478
[TBL] [Abstract][Full Text] [Related]
16. Intracellular Delivery of Anti-SMC2 Antibodies against Cancer Stem Cells.
Montero S; Seras-Franzoso J; Andrade F; Martinez-Trucharte F; Vilar-Hernández M; Quesada M; Xandri H; Arango D; Abasolo I; Rafael D; Schwartz S
Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32098204
[TBL] [Abstract][Full Text] [Related]
17. Mithramycin A Inhibits Colorectal Cancer Growth by Targeting Cancer Stem Cells.
Quarni W; Dutta R; Green R; Katiri S; Patel B; Mohapatra SS; Mohapatra S
Sci Rep; 2019 Oct; 9(1):15202. PubMed ID: 31645574
[TBL] [Abstract][Full Text] [Related]
18. Fab-conjugated PLGA nanoparticles effectively target cancer cells expressing human CD44v6.
Kennedy PJ; Sousa F; Ferreira D; Pereira C; Nestor M; Oliveira C; Granja PL; Sarmento B
Acta Biomater; 2018 Nov; 81():208-218. PubMed ID: 30267881
[TBL] [Abstract][Full Text] [Related]
19. Cancer Stem Cell-Based Models of Colorectal Cancer Reveal Molecular Determinants of Therapy Resistance.
De Angelis ML; Zeuner A; Policicchio E; Russo G; Bruselles A; Signore M; Vitale S; De Luca G; Pilozzi E; Boe A; Stassi G; Ricci-Vitiani L; Amoreo CA; Pagliuca A; Francescangeli F; Tartaglia M; De Maria R; Baiocchi M
Stem Cells Transl Med; 2016 Apr; 5(4):511-23. PubMed ID: 26956206
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.
Prabhu VV; Lulla AR; Madhukar NS; Ralff MD; Zhao D; Kline CLB; Van den Heuvel APJ; Lev A; Garnett MJ; McDermott U; Benes CH; Batchelor TT; Chi AS; Elemento O; Allen JE; El-Deiry WS
PLoS One; 2017; 12(8):e0180541. PubMed ID: 28767654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
